The modulation of tumor vessel permeability by thalidomide and its impacts on different types of targeted drug delivery systems in a sarcoma mouse model

doi:10.1016/j.jconrel.2016.07.014

CORC > 自动化研究所 > 中国科学院自动化研究所 > 中国科学院分子影像重点实验室

	The modulation of tumor vessel permeability by thalidomide and its impacts on different types of targeted drug delivery systems in a sarcoma mouse model
	Wang, Dan 1,2; Fu, Jijun 1,2; Shi, Yujie 1,2; Peng, Dong 3; Yuan, Lan 4; He, Bing 1,2; Dai, Wenbing 1,2; Zhang, Hua 1,2; Wang, Xueqing 1,2; Tian, Jie3
刊名	JOURNAL OF CONTROLLED RELEASE
	2016-09-28
卷号	238 页码:186-196
关键词	Targeted Drug Delivery Systems Animal Model Of Epr Effect Tumor Vessel Permeability Thalidomide Antitumor Efficacy Distribution
DOI	10.1016/j.jconrel.2016.07.014
文献子类	Article
英文摘要	The transport of nanocarriers is supposed to be based on EPR effect which is affected by diverse factors, so the modulation of EPR effect seems very significant for nanocarriers including targeted drug delivery systems (TDDSs). Besides, it is extremely unclear how the EPR effect impacts the fate of different types of TDDSs. To make the most advantage of EPR effect for TDDSs, it is definitely necessary to clarify these key issues. Here, we construct and characterize various TDDSs, including sterically-stabilized liposomes (SSL), RGD functionalized SSL (RGD-SSL) and novel 7PEP functionalized SSL (7PEP-SSL), loaded with doxorubicin (DOX), DIR or DID. Here, we modulate the permeability of tumor vessels by thalidomide (THD) in a sarcoma-bearing EPR mouse model via monitoring endogenous deoxygenated hemoglobin in circulation, and then we confirm the effect of THD on tumor vessel permeability by vessel density, vessel maturity, VEGF expression and so on. Importantly, we investigate and find the impacts of EPR effect on the antitumor efficacy, in vivo distribution and intratumoral microdistribution of the three TDDSs. Interestingly, the EPR effects affect different TDDSs differently. The elevated EPR effect enhances the tumor accumulation of SSL and RGD-SSL but fails to increase their efficacy. The RGD-SSL exhibits the best efficacy with the least fluctuation, demonstrating the advantage of angiogenesis targeted systems. 7PEP-SSL seems the biggest beneficiary of EPR effect, suggesting the significance of EPR modulation for cells targeted systems. Generally, this study demonstrates the feasibility of modulating EPR effect bidirectionally by THD as well as the impacts of EPR effect on different type of testing TDDSs based on this animal model. It certainly provides novel insight into the design and potential use of TDDSs. (C) 2016 Elsevier B.V. All rights reserved.
WOS关键词	MACROMOLECULAR THERAPEUTICS ; TRANSFERRIN RECEPTOR ; VASCULAR-PERMEABILITY ; CANCER-CHEMOTHERAPY ; BLOOD-VESSELS ; SOLID TUMORS ; RGD ; MICROENVIRONMENT ; CELLS ; NANOMEDICINES
WOS研究方向	Chemistry ; Pharmacology & Pharmacy
语种	英语
WOS记录号	WOS:000384699900018
资助机构	National Natural Science Foundation of China(81130059) ; National Basic Research Program of China (973 program)(2015CB932100)
内容类型	期刊论文
源URL	[http://ir.ia.ac.cn/handle/173211/12639]
专题	自动化研究所_中国科学院分子影像重点实验室
作者单位	1.Peking Univ, Beijing Key Lab Mol Pharmaceut, Beijing 100191, Peoples R China 2.Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China 3.Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging, Beijing 100190, Peoples R China 4.Peking Univ, Med & Hlth Analyt Ctr, Beijing 100191, Peoples R China
推荐引用方式 GB/T 7714	Wang, Dan,Fu, Jijun,Shi, Yujie,et al. The modulation of tumor vessel permeability by thalidomide and its impacts on different types of targeted drug delivery systems in a sarcoma mouse model[J]. JOURNAL OF CONTROLLED RELEASE,2016,238:186-196.
APA	Wang, Dan.,Fu, Jijun.,Shi, Yujie.,Peng, Dong.,Yuan, Lan.,...&Zhang, Qiang.(2016).The modulation of tumor vessel permeability by thalidomide and its impacts on different types of targeted drug delivery systems in a sarcoma mouse model.JOURNAL OF CONTROLLED RELEASE,238,186-196.
MLA	Wang, Dan,et al."The modulation of tumor vessel permeability by thalidomide and its impacts on different types of targeted drug delivery systems in a sarcoma mouse model".JOURNAL OF CONTROLLED RELEASE 238(2016):186-196.